TipRanks
Advertisement
Advertisement
Analyst Initiates Buy on Kailera, Citing Differentiated Obesity Pipeline and DCF-Based $30 Price Target
PremiumRatingsAnalyst Initiates Buy on Kailera, Citing Differentiated Obesity Pipeline and DCF-Based $30 Price Target
2M ago
Kailera Therapeutics appoints Nur Nicholson as chief technology officer
Premium
The Fly
Kailera Therapeutics appoints Nur Nicholson as chief technology officer
2M ago
Kailera Therapeutics announces positive Phase 3 data for weight loss drug
Premium
The Fly
Kailera Therapeutics announces positive Phase 3 data for weight loss drug
4M ago
Kailera Therapeutics initiated with a Buy at TD Cowen
PremiumThe FlyKailera Therapeutics initiated with a Buy at TD Cowen
5M ago
Kailera Therapeutics initiated with an Outperform at William Blair
Premium
The Fly
Kailera Therapeutics initiated with an Outperform at William Blair
5M ago
Kailera Therapeutics initiated with an Overweight at JPMorgan
Premium
The Fly
Kailera Therapeutics initiated with an Overweight at JPMorgan
5M ago
Kailera Stock (KLRA) Rockets 68% after IPO in Race for $150B Obesity Market
PremiumMarket NewsKailera Stock (KLRA) Rockets 68% after IPO in Race for $150B Obesity Market
6M ago
Kailera Therapeutics opens at $26, IPO priced at $16 per share
Premium
The Fly
Kailera Therapeutics opens at $26, IPO priced at $16 per share
6M ago
Kailera Therapeutics indicated to open at $21, IPO priced at $16
Premium
The Fly
Kailera Therapeutics indicated to open at $21, IPO priced at $16
6M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―